Future University In Egypt (FUE)
Future University is one of most promising private universities in Egypt. Through excellence in teaching, research and service, Future University strives to provide a comprehensive, high-quality education that prepares our graduates to be future leaders.
Altagamoa Al Khames, Main centre of town, end of 90th Street
New Cairo

Nouran Omar El Said

Basic information

Name : Nouran Omar El Said
Title: Lecturer
Google Schoolar Link
Personal Info: Nouran Omar, Lecturer at Pharmacy Practice & Clinical Pharmacy department , she got her Master degree in Clinical Pharmacy from Ain Shams University .


Certificate Major University Year
PhD Clinical Pharmacy 2021
Masters Clinical Pharamacy 2015
Bachelor 2006

Researches /Publications

A cross-sectional analysis of the association between diabetes self-care practices and blood glucose regulation among Egyptian diabetic patients

Nouran Omar Elsaid Elhanafy Nassar

E.A. Wahsh; A.E. Abou Warda; R.A. El-Gazar; A.A. Elshanbary; S.M. Elsayed



Download PDF
Impact of lipophilic vs hydrophilic statins on the clinical outcome and biomarkers of remodelling in heart failure patients: A prospective comparative randomized study

Nouran Omar Elsaid Elhanafy Nassar

Lamia Mohamed El Wakeel, Hazem Khorshid, Ebtissam Abdel Ghaffar Darweesh, Marwa Adel Ahmed


Aims: There are insufficient direct comparative studies addressing the impact of the type of statin on their respective efficacy in heart failure (HF). The aim of the current study was to compare the effects of lipophilic (atorvastatin) vs hydrophilic (rosuvastatin) on left ventricular function, inflammatory and fibrosis biomarkers in patients with chronic HF. Methods: This was a prospective, randomized, comparative, parallel study. A total of 85 patients with chronic HF optimized on guideline directed therapy were randomized to receive either atorvastatin 40 mg (n = 42) or rosuvastatin 20 mg (n = 43) for 6 months. Baseline and follow-up assessment included 2D echocardiography, measurement of N-terminal pro-brain natriuretic peptide, interleukin-6 and soluble suppression of tumorigenicity 2 (sST2) levels, liver enzymes and lipid profile. Results: The increase in left ventricular ejection fraction was significantly higher in the atorvastatin group compared to the rosuvastatin group (6.5% [3–11] vs 4% [2–5], P = .006). The reduction in left ventricular end diastolic and end systolic volume was comparable between the 2 groups. The decrease in sST2 levels in pg/mL was significantly higher in the atorvastatin compared to the rosuvastatin group (−255 [−383 to −109.8 vs − 151 [−216 to −69], P = .003). There was a significant reduction in Nterminal pro-brain natriuretic peptide and interleukin-6 levels in both groups, yet the reduction was comparable in both groups. Conclusion: The study results suggest that lipophilic atorvastatin is superior to hydrophilic rosuvastatin in increasing left ventricular ejection fraction and reducing fibrosis marker sST2 in HF patients. Trial registration ID: NCT03255044, registered on 21 August 2017. KEYWORDS heart failure, hydrophilic, lipophilic, remodelling, soluble ST2, statin

Download PDF
Alfuzosin Treatment Improves The Rate and Time for Stone Expulsion in Patients with Distal Uretral Stones: A Prospective Randomized Controlled Study

Nouran Omar Elsaid Elhanafy Nassar



Download PDF

Follow us on

Visit the Faculty